Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G, Himmetoglu C, Jimenez RE, Geyer SM, Wang WP, Costinean S, Pilarski RT, Morrison C, Suren D, Liu J, Chen J, Kamal J, Shapiro CL, Huebner K.
Guler G, et al. Among authors: himmetoglu c.
Breast Cancer Res Treat. 2011 Sep;129(2):421-32. doi: 10.1007/s10549-010-1248-6. Epub 2010 Nov 11.
Breast Cancer Res Treat. 2011.
PMID: 21069451
Free PMC article.